Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
12/2010
12/01/2010CN101899440A Structure and use of PITPNM2 targeted anti-dengue virus oligonucleotide
12/01/2010CN101899421A Recombinant baculovirus and construction method and application thereof
12/01/2010CN101899097A Blood group B epitope mimic peptide and application thereof
12/01/2010CN101899096A Blood group A epitope mimic peptide and application thereof
12/01/2010CN101897983A Monocyte-specific particulate delivery vehicle
12/01/2010CN101897982A SiRNA medicinal composition for treating cancers
12/01/2010CN101897981A Method for inhibiting proliferation and inducing apoptosis of cancer cells and use thereof
12/01/2010CN101897970A Compositions and methods for treating diabetes
12/01/2010CN101897953A Non-invasive high-penetrability epidermal growth factor and application thereof
12/01/2010CN101897951A Anti-inflammatory effect of novel anti-inflammatory molecular DRP, implementation method and application
12/01/2010CN101897950A Antiviral actions, implementation method and use of novel antiviral molecule DRP
12/01/2010CN101897669A Brain targeting drug delivery system
12/01/2010CN101575615B Construction of recombined lentivirus vector aiming at PKC gamma gene RNA interference and application thereof
12/01/2010CN101429260B Polymethacrylate, preparation method and application thereof
12/01/2010CN101380473B Gold nano-bar based medicine carrier and preparation technique and use thereof
12/01/2010CN101288671B Use of Triperugium wilfordii monomeric compound for increasing gene expression efficiency mediated by adeno-associated virus vector and subsidiarily treating neurodegenerative disease
12/01/2010CN101058808B Breast cancer relevant p60 gene, coding protein and application thereof
11/2010
11/30/2010US7842792 Compositions and methods for non-targeted activation of endogenous genes
11/30/2010US7842788 Metalloproteinase specific immunoglobulin for use in treatment and prevention of degradative diseases of connective tissue
11/30/2010US7842784 Antagonizing bone morphogenetic protein activity; utilizing polypeptide comprising amino acids 22-452 of sequence 8; bone diseases, tissue regeneration, wound healing
11/30/2010US7842673 introducing an oligonucleotide into a donor cell, particularly a stem cell, and contacting the target cell with the donor cell under conditions permitting the donor cell to form a gap junction channel composed of connexin 43 with the target cell, thus donor cell delivers oligonucleotide to target cell
11/30/2010US7842503 Hybrid recombinases for genome manipulation
11/30/2010US7842489 Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof
11/30/2010US7842310 Pharmaceutical compositions in particulate form
11/30/2010US7842304 Methods and apparatus for treating an injured nerve pathway
11/30/2010US7842297 raising an antibody specific for Chlamydia trachomatis elementary bodies (EB) in which a protein of the present invention is administered to a patient
11/30/2010US7842290 involved in the adaptation of microorganisms to its environment, particularly the identification of genes responsible for the virulence of a pathogenic microorganisms
11/30/2010US7842289 Polypeptides; antigens; vaccines; fusion protein containing signal peptide and polypeptide; genetic engineered Listeria bacteria
11/30/2010CA2295876C Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases
11/30/2010CA2259595C Dna immunization against chlamydia infection
11/30/2010CA2189740C Transgenic arthritic mice
11/25/2010WO2010135695A2 TREATMENT OF TRANSCRIPTION FACTOR E3 (TFE3) and INSULIN RECEPTOR SUBSTRATE 2 (IRS2) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO TFE3
11/25/2010WO2010135676A1 Engineered biological pacemakers
11/25/2010WO2010135329A2 Treatment of reprogramming factor related diseases by inhibition of natural antisense transcript to a reprogramming factor
11/25/2010WO2010133663A1 Serotonin 5-ht3 receptor antagonists for use in the treatment of lesional vestibular disorders
11/25/2010WO2010133369A1 Transfection method for nonviral gene delivery systems with improved activity by blocking the innate immune system
11/25/2010WO2010093452A3 Reducible polymers for non-viral gene delivery
11/25/2010WO2010090452A3 Small interference rna complex with increased intracellular transmission capacity
11/25/2010US20100299765 Modalities for the treatment of degenerative diseases of the retina
11/25/2010US20100298552 Emulsion compositions
11/25/2010US20100298420 Compositions and Methods for Intracellular Delivery
11/25/2010US20100298414 Development of a preventive vaccine for filovirus infection in primates
11/25/2010US20100298408 Oligonucleotide Compositions with Enhanced Efficiency
11/25/2010US20100297732 Vectors with modified protease-dependent tropism
11/25/2010US20100297731 Novel adenoviruses, nucleic acids that code for the same and the use of said viruses
11/25/2010US20100297695 Nucleic Acids Encoding Chimeric CD154 Polypeptides
11/25/2010US20100297650 Nucleic acid and corresponding protein entitled 193p1e1b useful in treatment and detection of cancer
11/25/2010US20100297171 Development of a preventive vaccine for filovirus infection in primates
11/25/2010US20100297154 CD40 ligand-enhanced cells and methods of modulating an immune response to an antigen
11/25/2010US20100297084 method for transducing cells with primary cilia
11/25/2010US20100297082 Weight-bearing polyurethane composites and methods thereof
11/25/2010US20100297061 Stat3 antagonists and their uses as vaccines against cancer
11/25/2010US20100297023 Lipid
11/25/2010CA2762987A1 Treatment of transcription factor e3 (tfe3) and insulin receptor substrate 2 (irs2) related diseases by inhibition of natural antisense transcript to tfe3
11/25/2010CA2762369A1 Treatment of reprogramming factor related diseases by inhibition of natural antisense transcript to a reprogramming factor
11/25/2010CA2761762A1 Serotonin 5-ht3 receptor antagonists for use in the treatment of lesional vestibular disorders
11/24/2010EP2253718A2 Solid surface for biomolecule delivery and high-throughput assay
11/24/2010EP2253706A2 Antisense modulation of kinesin-like 1 expression
11/24/2010EP2253645A2 Factor VIII Polypeptide
11/24/2010EP2253643A1 Novel compositions and methods in cancer associated with altered expression of PRLR
11/24/2010EP2253642A1 Polypeptides, cDNAs encoding the same and utilization thereof
11/24/2010EP2253639A1 Bi- and tri-cyclic nucleoside, nucleotide and oligonucleoide analogues
11/24/2010EP2253331A1 Modulation of antibody formation in mammals, applicability in gene therapy and animal model generation
11/24/2010EP2253316A1 serotonin 5-HT3 receptor antagonists for use in the treatment or prevention of vestibular deficits
11/24/2010EP2252688A1 Synthetic phosphodiester oligonucleotides and therapeutical uses thereof
11/24/2010EP2252329A2 Elimination of immune responses to viral vectors
11/24/2010EP2252316A2 Modulation of adenoviral tropism
11/24/2010EP1551988B1 Methods for generating enhanced antibody-producing cell lines with improved growth characteristics
11/24/2010EP1546375B1 Nucleic acids, polypeptides, and methods for modulating apoptosis
11/24/2010EP1438418B1 Stem cells of the islets of langerhans and their use in treating diabetes mellitus
11/24/2010EP1385948B1 Nucleic acids for inhibiting hairless protein expression and methods of use thereof
11/24/2010EP1355919B1 Molecules with extended half-lives, compositions and uses thereof
11/24/2010CN101892262A Construction and application of IRES (Internal Ribosome Entry Site) mediated four GH (Growth Hormone) subtypes and IGF-I (Insulin-like Growth Factor-I) bicistronic eukaryon co-expression vector
11/24/2010CN101892261A Recombinant adenovirus carrier and application thereof
11/24/2010CN101892255A Recombinant vector for regulating expression of two target genes by using promoter
11/24/2010CN101892249A Pufa polyketide synthase systems and uses thereof
11/24/2010CN101892240A Japanese blood fluke beta-catenin gene, protein and application
11/24/2010CN101892239A Schistosoma japonicum katsurada Frizzled 9 gene, protein and use
11/24/2010CN101892237A Polynucleotide related to mitochondrial membrane potential decrease and coded polypeptide and application thereof
11/24/2010CN101892236A Construction and application of RNA interference expression vector of targeted ZNF268 gene
11/24/2010CN101892235A MicroRNA used for inducing leukemia cell differentiation
11/24/2010CN101892226A Small interfering RNA (siRNA) for restraining ACC gene expression of human adipocyte and expression vector and application thereof
11/24/2010CN101891806A Anti-flavivirus envelope E protein monoclonal antibody and application thereof
11/24/2010CN101891803A New cartilaginous affinity polypeptide sequence, screening method and application thereof
11/24/2010CN101890172A Application of S100A16 gene in preparing drug for treating obesity
11/24/2010CN101890167A Conveniently implantable sustained release drug compositions
11/24/2010CN101890153A Method for treating chronic liver diseases by using hepatocyte nuclear factor-4alpha (HNF4alpha)
11/24/2010CN101205539B Highly pathogenic PRRS virus recombinant plasmid and genetic engineering vaccines
11/23/2010US7840263 Method and apparatus for device controlled gene expression
11/23/2010US7838664 used as modulators or targets of developmental processes or disorders associated with developmental dysfunctions, such as cancer; tumor suppressors genes
11/23/2010US7838663 used as modulators or targets of developmental processes or disorders associated with developmental dysfunctions, such as cancer; tumor suppressors genes
11/23/2010US7838662 used as modulators or targets of developmental processes or disorders associated with developmental dysfunctions, such as cancer; tumor suppressors genes
11/23/2010US7838661 used as modulators or targets of developmental processes or disorders associated with developmental dysfunctions, such as cancer; tumor suppressors genes
11/23/2010US7838660 used as modulators or targets of developmental processes or disorders associated with developmental dysfunctions, such as cancer; tumor suppressors genes
11/23/2010US7838658 siRNA silencing of filovirus gene expression
11/23/2010US7838657 compositions capable of blocking the inhibitory effect of a newly-identified intronic inhibitory sequence element, named ISS-N1 (intronic splicing silencer), located in the SMN2 gene
11/23/2010US7838648 Purified SR-p70 protein
11/23/2010US7838645 Function of autophagy genes in cell death
11/23/2010US7838639 antibody that specifically binds to a human TNF Receptor in the BRAIN (TRAIN) polypeptide; useful in regulating cell differentiation, death, and survival
11/23/2010US7838637 Single-chain multiple antigen-binding molecule, its preparation and use
1 ... 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 ... 870